{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:20:42Z","timestamp":1790436042787,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2003,3,1]]},"DOI":"10.1038\/sj.leu.2402821","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T15:24:54Z","timestamp":1048865094000},"page":"515-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Immunological classification of acute myeloblastic leukemias: relevance to patient outcome"],"prefix":"10.1038","volume":"17","author":[{"given":"R O","family":"Casasnovas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F K","family":"Slimane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Garand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G C","family":"Faure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Deneys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Falkenrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lecalvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Maynadi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"B\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,3,19]]},"reference":[{"key":"BF2402821_CR1","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9: 1783\u20131786.","journal-title":"Leukemia"},{"key":"BF2402821_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1046\/j.1365-2141.2001.02801.x","volume":"113","author":"MC Bene","year":"2001","unstructured":"Bene MC, Bernier M, Casasnovas RO, Castoldi G, Doekharan D, van der Holt B et al. Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients. Br J Haematol 2001; 113: 737\u2013745.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR3","first-page":"64","volume":"82","author":"E Matutes","year":"1997","unstructured":"Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M et al. Definition of acute biphenotypic leukemia. Haematologica 1997; 82: 64\u201366.","journal-title":"Haematologica"},{"key":"BF2402821_CR4","first-page":"739","volume":"4","author":"R Garand","year":"1990","unstructured":"Garand R, Vannier JP, Bene MC, Faure G, Favre M, Bernard A . Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucemies. Leukemia 1990; 4: 739\u2013744.","journal-title":"Leukemia"},{"key":"BF2402821_CR5","first-page":"161","volume":"7","author":"R Garand","year":"1993","unstructured":"Garand R, Voisin S, Papin S, Praloran V, Lenormand B, Favre M et al. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leuc\u00e9mies. Leukemia 1993; 7: 161\u2013167.","journal-title":"Leukemia"},{"key":"BF2402821_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.leu.2400893","volume":"12","author":"RO Casasnovas","year":"1998","unstructured":"Casasnovas RO, Campos L, Mugneret F, Charrin C, B\u00e9n\u00e9 MC, Garand R et al. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients. Leukemia 1998; 12: 34\u201343.","journal-title":"Leukemia"},{"key":"BF2402821_CR7","volume-title":"Clustering algorithms","author":"JA Hartigan","year":"1975","unstructured":"Hartigan JA . Clustering algorithms. New York: Wiley, 1975."},{"key":"BF2402821_CR8","volume-title":"Numerical Taxonomy","author":"PHA Sneath","year":"1973","unstructured":"Sneath PHA, Sokal RR . Numerical Taxonomy. San Francisco: WH Freeman & Co., 1973."},{"key":"BF2402821_CR9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V92.2.596","volume":"92","author":"MC Bene","year":"1998","unstructured":"Bene MC, Bernier M, Casasnovas RO, Castoldi G, Knapp W, Lanza F et al. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias. The European Group for the Immunological Classification of Leukemias (EGIL). Blood 1998; 92: 596\u2013599.","journal-title":"Blood"},{"key":"BF2402821_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2141.1992.tb06401.x","volume":"80","author":"V Buccheri","year":"1992","unstructured":"Buccheri V, Shetty V, Yoshida N, Morilla R, Matutes E, Catovsky D . The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry. Br J Haematol 1992; 80: 62\u201368.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451\u2013458.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR12","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V87.5.2020.2020","volume":"87","author":"HY Huh","year":"1996","unstructured":"Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL . Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996; 87: 2020\u20132028.","journal-title":"Blood"},{"key":"BF2402821_CR13","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/blood.V80.8.2105.2105","volume":"80","author":"MR van Schravendijk","year":"1992","unstructured":"van Schravendijk MR, Handunnetti SM, Barnwell JW, Howard RJ . Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells. Blood 1992; 80: 2105\u20132114.","journal-title":"Blood"},{"key":"BF2402821_CR14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V89.1.307","volume":"89","author":"SK Lo","year":"1997","unstructured":"Lo SK, Golenbock DT, Sass PM, Maskati A, Xu H, Silverstein RL . Engagement of the Lewis X antigen (CD15) results in monocyte activation. Blood 1997; 89: 307\u2013314.","journal-title":"Blood"},{"key":"BF2402821_CR15","first-page":"501","volume":"94","author":"HF Tien","year":"1996","unstructured":"Tien HF, Chou CC, Wang CH, Chang CH, Hsing CC . Putative normal counterparts of leukaemic cells from CD7-positive acute myeloid leukaemia can be demonstrated in human haemopoietic tissues. Br J Haematol 1996; 94: 501\u2013506.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR16","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.149.6.2110","volume":"149","author":"C Chabannon","year":"1992","unstructured":"Chabannon C, Wood P, Torok-Storb B . Expression of CD7 on normal human myeloid progenitors. J Immunol 1992; 149: 2110\u20132113.","journal-title":"J Immunol"},{"key":"BF2402821_CR17","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood.V82.11.3401.3401","volume":"82","author":"A Barcena","year":"1993","unstructured":"Barcena A, Muench MO, Galy AH, Cupp J, Roncarolo MG, Phillips JH et al. Phenotypic and functional analysis of T-cell precursors in the human fetal liver and thymus: CD7 expression in the early stages of T- and myeloid-cell development. Blood 1993; 82: 3401\u20133414.","journal-title":"Blood"},{"key":"BF2402821_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE . Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730\u2013737.","journal-title":"Nat Med"},{"key":"BF2402821_CR19","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood.V78.5.1292.1292","volume":"78","author":"AW Jensen","year":"1991","unstructured":"Jensen AW, Hokland M, Jorgensen H, Justesen J, Ellegaard J, Hokland P . Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis. Blood 1991; 78: 1292\u20131300.","journal-title":"Blood"},{"key":"BF2402821_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.leu.2401067","volume":"12","author":"A Venditti","year":"1998","unstructured":"Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia 1998; 12: 1056\u20131063.","journal-title":"Leukemia"},{"key":"BF2402821_CR21","first-page":"393","volume":"6","author":"E Solary","year":"1992","unstructured":"Solary E, Casasnovas RO, Campos L, Bene MC, Faure G, Maingon P et al. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+\/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucemies (GEIL). Leukemia 1992; 6: 393\u2013399.","journal-title":"Groupe d'Etude Immunologique des Leucemies (GEIL). Leukemia"},{"key":"BF2402821_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0145-2126(97)00100-8","volume":"22","author":"M Fergedal","year":"1998","unstructured":"Fergedal M, Astrom M, Tidefelt U, Karlsson MG . Differences in CD14 and alpha-naphthyl acetate esterase positivity and relation to prognosis in AML. Leuk Res 1998; 22: 25\u201330.","journal-title":"Leuk Res"},{"key":"BF2402821_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2141.1989.tb07677.x","volume":"72","author":"L Campos","year":"1989","unstructured":"Campos L, Guyotat D, Archimbaud E, Devaux Y, Treille D, Larese A et al. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol 1989; 72: 161\u2013166.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR24","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood.V84.4.1220.1220","volume":"84","author":"K Bradstock","year":"1994","unstructured":"Bradstock K, Matthews J, Benson E, Page F, Bishop J . Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group. Blood 1994; 84: 1220\u20131225.","journal-title":"Blood"},{"key":"BF2402821_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/10428199509051710","volume":"17","author":"G Del Poeta","year":"1995","unstructured":"Del Poeta G, Stasi R, Venditti A, Cox C, Aronica G, Masi M et al. CD7 expression in acute myeloid leukemia. Leuk Lymphoma 1995; 17: 111\u2013119.","journal-title":"Leuk Lymphoma"},{"key":"BF2402821_CR26","first-page":"388","volume":"8","author":"G Del Poeta","year":"1994","unstructured":"Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A et al. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994; 8: 388\u2013394.","journal-title":"Leukemia"},{"key":"BF2402821_CR27","first-page":"1203","volume":"6","author":"EJ Lee","year":"1992","unstructured":"Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A et al. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 1992; 6: 1203\u20131209.","journal-title":"Leukemia"},{"key":"BF2402821_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2141.1990.tb06365.x","volume":"76","author":"RB Geller","year":"1990","unstructured":"Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S et al. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10). Br J Haematol 1990; 76: 340\u2013347.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/1097-0142(19920115)69:2<396::AID-CNCR2820690220>3.0.CO;2-E","volume":"69","author":"R Bassan","year":"1992","unstructured":"Bassan R, Biondi A, Benvestito S, Tini ML, Abbate M, Viero P, Barbui T et al. Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features. Cancer 1992; 69: 396\u2013404.","journal-title":"Cancer"},{"key":"BF2402821_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.1989.tb07747.x","volume":"73","author":"H Merle-Beral","year":"1989","unstructured":"Merle-Beral H, Nguyen Cong Duc L, Leblond V, Boucheix C, Michel A et al. Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia. Br J Haematol 1989; 73: 323\u2013330.","journal-title":"Br J Haematol"},{"key":"BF2402821_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.1990.8.3.423","volume":"8","author":"I Schwarzinger","year":"1990","unstructured":"Schwarzinger I, Valent P, Koller U, Marosi C, Schneider B, Haas O Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. J Clin Oncol 1990; 8: 423\u2013430.","journal-title":"J Clin Oncol"},{"key":"BF2402821_CR32","first-page":"239","volume":"21","author":"H Miwa","year":"1996","unstructured":"Miwa H, Nakase K, Kita K . Biological characteristics of CD7(+) acute leukemia. Leuk Lymphoma 1996; 21: 239\u2013244.","journal-title":"Leuk Lymphoma"},{"key":"BF2402821_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<278::AID-AJH5>3.0.CO;2-N","volume":"58","author":"A Saxena","year":"1998","unstructured":"Saxena A, Sheridan DP, Card RT, McPeek AM, Mewdell CC, Skinnider LF . Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol 1998; 58: 278\u2013284.","journal-title":"Am J Hematol"},{"key":"BF2402821_CR34","first-page":"1735","volume":"9","author":"SM Kornblau","year":"1995","unstructured":"Kornblau SM, Thall P, Huh YO, Estey E, Andreeff M . Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with \u2018optimal\u2019 cutpoint analysis reveals absence of prognostic significance. Leukemia 1995; 9: 1735\u20131741.","journal-title":"Leukemia"},{"key":"BF2402821_CR35","first-page":"258","volume":"8","author":"MA Reuss Borst","year":"1994","unstructured":"Reuss Borst MA, B\u00fchring HJ, Schmidt H, M\u00fcller CA . AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8: 258\u2013263.","journal-title":"Leukemia"},{"key":"BF2402821_CR36","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/1097-0142(20000601)88:11<2529::AID-CNCR14>3.0.CO;2-S","volume":"88","author":"Y Kanda","year":"2000","unstructured":"Kanda Y, Hamaki T, Yamamoto R, Chizuka A, Suguro M, Matsuyama T et al. The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia: an overview of 2483 patients from 22 studies. Cancer 2000; 88: 2529\u20132533.","journal-title":"Cancer"},{"key":"BF2402821_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<265::AID-AJH24>3.0.CO;2-8","volume":"57","author":"K Kyoda","year":"1998","unstructured":"Kyoda K, Nakamura S, Hattori N, Takeshima M, Nakamura K, Kaya H et al. Lack of prognostic significance of CD34 expression in adult AML when FAB M0 and M3 are excluded. Am J Hematol 1998; 57: 265\u2013266.","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"BF2402821_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/10428199409052681","volume":"13","author":"F Lanza","year":"1994","unstructured":"Lanza F, Rigolin GM, Moretti S, Latorraca A, Castoldi G . Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Leuk Lymphoma 1994; 13(Suppl 1): 81\u201385.","journal-title":"Leuk Lymphoma"},{"key":"BF2402821_CR39","first-page":"151","volume":"78","author":"S Ciolli","year":"1993","unstructured":"Ciolli S, Leoni F, Caporale R, Pascarella A, Salti F, Rossi-Ferrini P . CD34 expression fails to predict the outcome in adult acute myeloid leukemia. Haematologica 1993; 78: 151\u2013155.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402821","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:09:31Z","timestamp":1682467771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3,1]]}},"alternative-id":["BF2402821"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402821","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,1]]},"assertion":[{"value":"28 May 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}